Showing results (1301-1310 of 1,650) with videos related to
Sort By:
Pageof 165
Therapeutic Innovation & Regulatory Science|February 20, 2020
Evaluation of Legal Legislation Compliance and Readability of Clinical Trial Informed Consent FormsBuket Gungor, Mualla Aylin, Ayse Asena, et al.Therapeutic Innovation & Regulatory Science|February 8, 2020
Multiplicity Adjustment and Sample Size Calculation in Clinical Trials with Multiple Endpoints: An Industry Survey of Current Practices in JapanKentaro Sakamaki, Yusuke Morita, Katsuhiro Iba, et al.Therapeutic Innovation & Regulatory Science|February 11, 2020
Correction to: A Comprehensive Analysis of Postmarket Surveillance Study Orders: Device Characteristics, Study Statuses, Outcomes, and Potential ContributionsChie Iwaishi, Kiyotaka IwasakiTherapeutic Innovation & Regulatory Science|January 29, 2020
A Comparative Study of the Market Configuration of the Japanese Pharmaceutical Market Using the Gini Coefficient and Herfindahl-Hirschman IndexShoyo Shibata, Daigo Fukumoto, Takeshi Suzuki, et al.Therapeutic Innovation & Regulatory Science|November 19, 2020
Patient Feedback on a Warfarin Action Plan Used in a Local Australian Physician Practice SettingAngela W P Yiu, Vincent W Lee, Kingsley K Ng, et al.Therapeutic Innovation & Regulatory Science|October 23, 2020
Over-the-Counter Drugs: Regulatory Analysis of Warning Letters Between Fiscal Years 2015-2019Helen K Bai, Jennifer D Ahearn, Michael G BartlettTherapeutic Innovation & Regulatory Science|September 21, 2020
Graphical Analyses in the Regulatory Evaluation of Gene Therapy ApplicationsXue Lin, Shiowjen Lee, John Scott, et al.Therapeutic Innovation & Regulatory Science|September 21, 2020
Bayesian Design for Pediatric Clinical Trials with Binary Endpoints When Borrowing Historical Information of Treatment EffectMan Jin, Qing Li, Amarjot KaurTherapeutic Innovation & Regulatory Science|September 14, 2020
Evolving Clinical Data Strategies and Tactics in Response to Digital TransformationBeth Harper, Michael Wilkinson, Raj Indupuri, et al.Therapeutic Innovation & Regulatory Science|September 1, 2020
Pediatric Drug Development in Japan: A Comparison of the Current Situation and Characteristics Between Japan and EuropeEiji Ueyama, Masayuki Kaneko, Mamoru NarukawaPageof 165